USANA Health Sciences (USNA) Tops Q2 EPS by 16c; Reiterates Guidance

July 27, 2021 4:19 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.87, $0.16 better than the analyst estimate of $1.71. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $332.61 million.

GUIDANCE:

Reiterates 2021 net sales and diluted EPS outlook.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings